Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Cyclo Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +3 vs. Q1 2021
- Shares held
- 263.7K
- +192.3K (+269.3%) vs. Q1 2021
- Total value
- $2.70M
- +$2.11M (+360.9%) vs. Q1 2021
- New holders
- 4
- 6 more added
- Sold out
- 1
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 22 | $1.33M |
| Q3 2024 | 19 | $1.80M |
| Q2 2024 | 22 | $2.84M |
| Q1 2024 | 22 | $3.01M |
| Q4 2023 | 23 | $2.06M |
| Q3 2023 | 17 | $682.7K |
| Q2 2023 | 14 | $725.2K |
| Q1 2023 | 16 | $820.2K |
| Q4 2022 | 15 | $1.83M |
| Q3 2022 | 12 | $768.0K |
| Q2 2022 | 13 | $794.0K |
| Q1 2022 | 13 | $1.38M |
| Q4 2021 | 15 | $1.71M |
| Q3 2021 | 13 | $2.23M |
| Q2 2021 | 12 | $2.70M |
| Q1 2021 | 9 | $585.0K |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Cyclo Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 151,540 | $1.55M | 0.00% | +117,895+350.4% | Added |
| State Street Corp | 44,700 | $457.0K | 0.00% | +44,700 | New |
| Geode Capital Management, LLC | 42,577 | $435.0K | 0.00% | +24,320+133.2% | Added |
| UBS Group AG | 11,094 | $113.0K | 0.00% | +10,396+1,489.4% | Added |
| BlackRock Inc. | 10,844 | $111.0K | 0.00% | +10,844 | New |
| Morgan Stanley | 1,403 | $14.0K | 0.00% | +900+178.9% | Added |
| Royal Bank of Canada | 746 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 565 | $6.00K | 0.00% | +371+191.2% | Added |
| Captrust Financial Advisors | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 100 | $1.00K | 0.00% | +100 | New |
| Wells Fargo & Company | 36 | $0 | 0.00% | +12+50.0% | Added |
| IFP Advisors, Inc | 13 | $0 | 0.00% | +13 | New |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −17,235−100.0% | Sold out |